← FDA DRUG APPROVALS

FDA ANDA · ANDA077819

METRONIDAZOLE

Sponsor: TARO

APPLICATION
ANDA077819
TYPE
ANDA
ORIGINAL APPROVAL
2006-07-18
LATEST ACTION
2012-03-28
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription

Products

METRONIDAZOLEPrescription
METRONIDAZOLE 0.75% · GEL · TOPICAL

Approval history

2012-03-28Labeling · Supplement 1AP
2006-07-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →